Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Biogen (BIIB) upgraded to Overweight from Neutral at Piper Sandler with analyst Christopher Raymond saying two new data points are "too positive to ignore," making the "path of least resistance on this stock is decidedly higher." 2. National Health (NHI) upgraded to Market Perform from Underperform at BMO Capital with analyst John Kim seeing a more balanced risk/reward profile with "upside to the dividend from here" after the company cut the dividend a "conservative" 18%. 3. Saia (SAIA) upgraded to Overweight from Equal Weight at Wells Fargo with analyst Allison Poliniak-Cusic saying consolidation among the carriers, which has resulted in improved pricing discipline this cycle coupled with the firm's view of an industrial recovery into 2022, positions the LTL sector favorably, and those dynamics should have a positive impact on tonnage growth, pricing dynamics, and return metrics such as the evolution of FCF and ROIC. 4. Lennar (LEN) upgraded to Overweight from Neutral at JPMorgan with analyst Michael Rehaut saying the stock is attractive relative to peers and does not reflect the company's "significant and ongoing" business transformation. 5. Orion Engineered (OEC) upgraded on favorable demand conditions at JPMorgan with analyst Jeffrey Zekauskas saying June quarter demand conditions for the carbon black producers are favorable. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.